ArticleBMJ public health2026
Smoking-attributable hospitalisation costs in Europe: an econometric analysis of the European Health Interview Survey, 2019.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite significant progress achieved in the past decade, the European Union (EU) tobacco epidemic remains one of the world's most important. As the decline in smoking prevalence stagnated in the past years and little legislative progress has been made in tobacco control policies, we provide updated estimates of the healthcare costs of smoking in the EU. Methods: The study uses 2019 data from the European Health Interview Survey, covering all EU Member States except for France, Germany, Ireland and Sweden, which are excluded because of data access and data quality reasons. We apply econometric methods to examine the differential use of inpatient and daycare hospitalisation services among smokers and never smokers. Based on the model estimates, we compute the smoking-attributable costs for these hospital services across Member States. Results: We find that smoking is positively associated with inpatient and daycare hospitalisation. Across countries, smoking-related costs range from EUR 5 billion (Spain) to EUR 28 million (Latvia) for inpatient hospitalisation, and from EUR 550 million (Netherlands) to EUR 3 million (Malta and Slovenia) for daycare services. Conclusions: The results of this paper show that smoking imposes significant healthcare costs across the EU. Importantly, the total healthcare costs of smoking are likely to be significantly higher than reported in this study, which only focuses on two types of healthcare services. These updated estimates underscore the need to reinvigorate tobacco control policies at national and EU level to reduce the health and economic burden of smoking and protect the health systems resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.